These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25338303)

  • 21. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic unmasking of epigenetically silenced genes in breast cancer.
    Ostrow KL; Park HL; Hoque MO; Kim MS; Liu J; Argani P; Westra W; Van Criekinge W; Sidransky D
    Clin Cancer Res; 2009 Feb; 15(4):1184-91. PubMed ID: 19228724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
    Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
    BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E4bp4 regulates carboxylesterase 2 enzymes through repression of the nuclear receptor Rev-erbα in mice.
    Zhao M; Zhang T; Yu F; Guo L; Wu B
    Biochem Pharmacol; 2018 Jun; 152():293-301. PubMed ID: 29653076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF; Dai DQ; Guo KJ
    Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells.
    Zhang M; Wang Q; Yuan W; Yang S; Wang X; Yan JD; Du J; Yin J; Gao SY; Sun BC; Zhu TH
    J Steroid Biochem Mol Biol; 2007; 105(1-5):91-7. PubMed ID: 17574840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients.
    Wahabi K; Perwez A; Kamarudheen S; Bhat ZI; Mehta A; Rizvi MMA
    BMC Cancer; 2019 Aug; 19(1):820. PubMed ID: 31429726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.
    Al-Nakhle H; Smith L; Bell SM; Burns PA; Cummings M; Hanby AM; Lane S; Parker MD; Hughes TA; Speirs V
    Int J Oncol; 2013 Dec; 43(6):2039-45. PubMed ID: 24068253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.
    Pan J; Chen Y; Mo C; Wang D; Chen J; Mao X; Guo S; Zhuang J; Qiu S
    PLoS One; 2014; 9(3):e92815. PubMed ID: 24664224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
    Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
    BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.
    Wiesmann F; Veeck J; Galm O; Hartmann A; Esteller M; Knüchel R; Dahl E
    Breast Cancer Res; 2009; 11(3):R34. PubMed ID: 19527488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
    Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
    Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3.
    Li X; Wu Y; Liu A; Tang X
    Biochem Biophys Res Commun; 2016 Sep; 477(4):768-773. PubMed ID: 27363334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
    Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4.
    Zhang Y; Yang YL; Zhang FL; Liao XH; Shao ZM; Li DQ
    Cancer Med; 2018 Apr; 7(4):1317-1325. PubMed ID: 29473320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
    Lo PH; Tanikawa C; Katagiri T; Nakamura Y; Matsuda K
    Oncol Rep; 2015 Jan; 33(1):267-73. PubMed ID: 25370079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.